BPG is committed to discovery and dissemination of knowledge
Featured Articles
4/7/2023 6:41:55 AM | Browse: 302 | Download: 1090
 |
Received |
|
2022-11-29 09:50 |
|
Peer-Review Started |
|
2022-11-29 09:51 |
|
First Decision by Editorial Office Director |
|
2022-12-19 23:29 |
|
Return for Revision |
|
2022-12-19 23:29 |
|
Revised |
|
2022-12-25 07:35 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2023-03-20 03:15 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2023-03-20 09:29 |
|
Articles in Press |
|
2023-03-20 09:29 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2023-03-26 15:12 |
|
Publish the Manuscript Online |
|
2023-04-07 05:51 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Minireviews |
| Article Title |
Interferon-lambda: New role in intestinal symptoms of COVID-19
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Yi-Yang Pan, Liu-Can Wang, Feng Yang and Min Yu |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Natural Science Foundation of China (to M.Y.) |
81970468 |
|
| Corresponding Author |
Min Yu, PhD, Professor, Department of General Surgery, Chongqing general Hospital, No. 118 Xingguang Avenue, Liangjiang New District, Chongqing 400013, China. yumimianbao@163.com |
| Key Words |
COVID-19; SARS-CoV-2; Interferon-λ; Gastrointestinal infection; Mechanism; Anti-viral response |
| Core Tip |
The tremendous public health and economic impact of the coronavirus disease 2019 caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become a huge challenge for countries across the whole world. Increased evidences have revealed that SARS-CoV-2 also induced intestinal infection. Type III interferon (IFN), also called IFN-λ, plays an antiviral role in intestinal infection, and has focused, long-lasting, as well as non-inflammatory characteristics. In this review, we summarized the invasion and immune escape mechanisms of the SARS-CoV-2. Furthermore, we concerned about the gastrointestinal impact of the SARS-CoV-2 and the comprehensive role of IFN-λ, also called type III IFN, in anti-enteric SARS-CoV-2 infection. |
| Publish Date |
2023-04-07 05:51 |
| Citation |
Pan YY, Wang LC, Yang F, Yu M. Interferon-lambda: New role in intestinal symptoms of COVID-19. World J Gastroenterol 2023; 29(13): 1942-1954 |
| URL |
https://www.wjgnet.com/1007-9327/full/v29/i13/1942.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v29.i13.1942 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
